Science & Enterprise subscription

Follow us on Twitter

  • Then "Day at the Races"
    about 13 hours ago
  • The Forward, America’s Leading Jewish News Organization, Goes All Digital. Third-generation subscriber here and wor…
    about 15 hours ago
  • Our friends at Statista reported on a survey on how the shutdown is affecting people in the U.S., this weekend's in…
    about 18 hours ago
  • New post on Science and Enterprise: Infographic – Americans Affected by Gov’t Shutdown #Science #Business
    about 18 hours ago
  • New contributed post on Science and Enterprise: Hands Off! Robots in Modern Medicine
    about 19 hours ago

Please share Science & Enterprise

Follow by Email
Visit Us

Novartis to Close U.K. Plant, Consolidate R&D Sites

Closed sign (Artaxerxes, Wikimedia Commons)The pharmaceutical company Novartis, headquartered in Basel, Switzerland, says it has begun talks to close its factory in Horsham, U.K. and consolidate its R&D facilities in Europe. According to the Financial Times, Novartis will continue its other U.K. plants in Grimsby, Liverpool, and Dundee.

Closing the Horsham plant will mean the loss of 550 jobs, says the Financial Times. The company will keep its research group in Horsham working on respiratory diseases and other support functions, according to Pharma Times, an industry newsletter. Those functions employ about 400 in Horsham.

Pharma Times also says Novartis plans to move some of its research and manufacturing units to other existing company locations. Over the next two years, its gastrointestinal research teams will co-locate at Novartis’s sites in Cambridge and Basel. The publication says Novartis U.K.’s over-the-counter operations will move in with or near to the Novartis site in Frimley, U.K.

The Novartis plant closing is the second such announcement involving pharmaceutical companies in the U.K. in as many months. In February, the U.S. pharma company Pfizer said it would close its R&D facility in Sandwich, with a loss of 2,400 jobs.

Read more: Pfizer Slashes R&D Funding, Closes U.K. Research Site

*     *     *

Please share Science & Enterprise ...

1 comment to Novartis to Close U.K. Plant, Consolidate R&D Sites